Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Batch-to-Batch Variation and Patient Heterogeneity in Thymoglobulin Binding and Specificity: One Size Does Not Fit All.Journal of clinical medicine · 2025
   Article
2. A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.Frontiers in immunology · 2018
   Article
3. Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats.Yonsei medical journal · 2017
   Article
4. Updates on Immune Therapies in Type 1 Diabetes.European endocrinology · 2016
   Review
5. Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.Diabetes technology & therapeutics · 2013
   Article
6. Efforts to prevent and halt autoimmune beta cell destruction.Endocrinology and metabolism clinics of North America · 2010
   Review
7. Stem cells as a therapeutic target for diabetes.Frontiers in bioscience (Landmark edition) · 2010
   Review
8. Stem cells derived from cord blood in transplantation and regenerative medicine.Deutsches Arzteblatt international · 2009
   Review

Corrections and comments

• Comment on
  C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.2009

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as